01dragonslayer
Iron Killer
Mad Referrer
Jacked Immortal
EG Auction Sniper
VIP Member
Shout Master
Mutated
Fully Loaded
- EG Cash
- 1,113,693
Question: “I ‘m interested in boldenone propionate. What advantages could it give me compared to other short acting esters? I don’t want to use trenbolone acetate again, as at even 50 mg/day I’m really a bastard to my girlfriend, even more so than usual. More importantly, I don’t sleep well. And I’m not a fan of testosterone propionate due to post-injection pain. I’ve never used boldenone at all, so can you tell me about it?”
Answer: The idea of boldenone propionate is great, as personal opinion. Boldenone has a relatively favorable side effect profile compared to most other anabolic steroids. Conversion to estrogen is low, and if anything the modest amount of conversion can be beneficial if no other aromatizing steroid is being used. Unlike testosterone, it’s not potentiated in the skin or scalp. Boldenone typically has little in the way of adverse effect on mood. The most common problems are increased appetite (in cases where that’s experienced as a problem) and at higher doses, sometimes a feverish feeling. But in general, it’s very well tolerated at modest dosages such as up to 400-500 mg/week and sometimes more.
Problem, however, can result from the long half life of the undecylenate ester form typically used for boldenone, as in the Equipoise product. The half life of up to about 2 weeks results in very slow transition from anabolically-useful high androgen levels to recovery-permitting low androgen levels.
For example, let’s say that 500 mg/week Equipoise is being taken as the injectable part of a steroid stack. That, particularly in combination with an oral, can be very effective.
A week after the last injection, really we would like recovery to be occurring. It won’t be, however. Blood levels of boldenone will be comparable to ongoing use of about 350 mg/week of Equipoise. Such a level on its own might provide a slow degree of anabolic effectiveness relative to a starting natural state, but after the gains of a cycle have already been made, this is far too little for still-further gains. Recovery won’t occur and neither willgains. Time of HPTA suppression, however, will accumulate.
How about 2 weeks after the last injection? Levels are now comparable to ongoing use of about 250 mg/week. Same story.
Typically, in practice with an Equipoise cycle it’s about a month before good recovery can begin (it can be less with lower dosages.)
Boldenone propionate, in contrast, has a half-life of probably only about two days. It would provide a very sharp transition of blood levels. So you would be either making progress anabolically, or be starting your recovery.
The theory offers promise.
In practice, boldenone propionate injections are exceptionally painful. Personally, I find even 25 mg/mL concentration to be unacceptable for use. Others also have had findings of greater pain with this injection than any other.
Hypothetically, either the phenylpropionate or acetate ester of boldenone might well provide the benefit of short half-life and pain-free injection, but so far as I know these are not available.
I would suggest either trying testosterone propionate at only a 50 mg/mL concentration, which can be painless, or testosterone acetate at that same concentration, or no more than 100 mg/mL.
Answer: The idea of boldenone propionate is great, as personal opinion. Boldenone has a relatively favorable side effect profile compared to most other anabolic steroids. Conversion to estrogen is low, and if anything the modest amount of conversion can be beneficial if no other aromatizing steroid is being used. Unlike testosterone, it’s not potentiated in the skin or scalp. Boldenone typically has little in the way of adverse effect on mood. The most common problems are increased appetite (in cases where that’s experienced as a problem) and at higher doses, sometimes a feverish feeling. But in general, it’s very well tolerated at modest dosages such as up to 400-500 mg/week and sometimes more.
Problem, however, can result from the long half life of the undecylenate ester form typically used for boldenone, as in the Equipoise product. The half life of up to about 2 weeks results in very slow transition from anabolically-useful high androgen levels to recovery-permitting low androgen levels.
For example, let’s say that 500 mg/week Equipoise is being taken as the injectable part of a steroid stack. That, particularly in combination with an oral, can be very effective.
A week after the last injection, really we would like recovery to be occurring. It won’t be, however. Blood levels of boldenone will be comparable to ongoing use of about 350 mg/week of Equipoise. Such a level on its own might provide a slow degree of anabolic effectiveness relative to a starting natural state, but after the gains of a cycle have already been made, this is far too little for still-further gains. Recovery won’t occur and neither willgains. Time of HPTA suppression, however, will accumulate.
How about 2 weeks after the last injection? Levels are now comparable to ongoing use of about 250 mg/week. Same story.
Typically, in practice with an Equipoise cycle it’s about a month before good recovery can begin (it can be less with lower dosages.)
Boldenone propionate, in contrast, has a half-life of probably only about two days. It would provide a very sharp transition of blood levels. So you would be either making progress anabolically, or be starting your recovery.
The theory offers promise.
In practice, boldenone propionate injections are exceptionally painful. Personally, I find even 25 mg/mL concentration to be unacceptable for use. Others also have had findings of greater pain with this injection than any other.
Hypothetically, either the phenylpropionate or acetate ester of boldenone might well provide the benefit of short half-life and pain-free injection, but so far as I know these are not available.
I would suggest either trying testosterone propionate at only a 50 mg/mL concentration, which can be painless, or testosterone acetate at that same concentration, or no more than 100 mg/mL.
